| A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma. (NCT01704495) | AstraZeneca | 2012-11-01 |
| Evaluation of a Shared Decision Making Portal for Pediatric Asthma (NCT01715389) | Children's Hospital of Philadelphia | 2012-11-01 |
| Multiple-dose Pharmacokinetics Study of "SYN006 HFA MDI" Administered Orally to Healthy Volunteers (NCT02165033) | Intech Biopharm Ltd. | 2012-11-01 |
| Does Asthma Phenotype Have Impact on Disease Control (NCT01978678) | Bispebjerg Hospital | 2012-11-01 |
| Severe Asthma Research Program (SARP)- San Francisco Clinical Site (NCT01718197) | University of California, San Francisco | 2012-11-01 |
| Impact of a Curriculum Intervention on Asthma Knowledge in Adolescents of a Public School in Salvador-Bahia-Brazil (NCT02142179) | Federal University of Bahia | 2012-11-01 |
| Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults (NCT01737892) | Amphastar Pharmaceuticals, Inc. | 2012-11-01 |
| Effect of in Vitro Blocking the Common Beta Chain on Cell Viability in Asthma (NCT01759849) | Hamilton Health Sciences Corporation | 2012-11-01 |
| Dose Finding Study of Albuterol Sulfate in Patients With Intermittent or Persistent Mild Asthma (NCT01252758) | Acerus Pharmaceuticals Corporation | 2012-11-01 |
| A Study Assessing Patient Handling of Flutiform® Breath-Actuated Inhaler (BAI) and Flutiform® Pressurised Metered Dose Inhaler (pMDI) (NCT01739387) | Mundipharma Research Limited | 2012-11-01 |
| Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma (NCT01691521) | GlaxoSmithKline | 2012-10-08 |
| Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma (NCT01720069) | Vectura Limited | 2012-10-01 |
| Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD) (NCT01721291) | Imperial College London | 2012-10-01 |
| Trial of Asthma Self-Management Education in Patients With Depressive Symptoms (NCT01708070) | Hospital for Special Surgery, New York | 2012-10-01 |
| Safety Study of Albuterol Spiromax® in Subjects With Asthma (NCT01698320) | Teva Branded Pharmaceutical Products R&D, Inc. | 2012-10-01 |
| A Study to Evaluate the Efficacy After Allergen Challenge, Safety and Tolerability of Inhaled CHF6001 DPI in Asthmatics (NCT01689571) | Chiesi Farmaceutici S.p.A. | 2012-10-01 |
| Diagnosing Pneumonia Under Low-resource Conditions (NCT01997047) | University of British Columbia | 2012-10-01 |
| Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom (NCT01715493) | Eisai Co., Ltd. | 2012-10-01 |
| Washington University Severe Asthma Research Program III (NCT01716494) | Washington University School of Medicine | 2012-10-01 |
| Stepping Down of Asthma Medication in Controlled Asthma (NCT01961154) | Kuopio University Hospital | 2012-10-01 |
| A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial (NCT01696214) | University of California, San Diego | 2012-10-01 |
| Safety and Efficacy of the Inspiromatic Inhaler in Comparison to the Aerolizer Inhaler When Delivering Formoterol (NCT01711086) | Guy Steuer | 2012-10-01 |
| Study to Evaluate the Impact of FeNO Assessments on Asthma Management Decisions in Subject 7 to 60 Years of Age (NCT01729247) | Aerocrine AB | 2012-10-01 |
| Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment (NCT01537133) | Milton S. Hershey Medical Center | 2012-10-01 |
| Vitamin D Deficiency and Asthma Exacerbation (NCT02661191) | University of Turin, Italy | 2012-10-01 |
| Severe Asthma Research Program (NCT01606826) | Milton S. Hershey Medical Center | 2012-10-01 |
| Bronchodilating and Bronchoprotective Effects of Deep Inspirations (NCT01659476) | Queen's University | 2012-10-01 |
| Efficacy of School-Based, Peer-Led Asthma and Smoking Prevention Program on CO1 Levels and Smoking Behavior Among Early Adolescents in Jordan (NCT01938976) | University of Technology, Sydney | 2012-10-01 |
| Control and Burden of Asthma and Rhinitis (NCT01771120) | Universidade do Porto | 2012-10-01 |
| Improving the Quality of Private Sector Health Care in West Bengal (NCT02291575) | Abdul Latif Jameel Poverty Action Lab | 2012-10-01 |
| Non-Invasive Neurostimulation of the Vagus Nerve With the AlphaCore Device for the Relief of EIB (NCT01923272) | ElectroCore INC | 2012-10-01 |
| Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma (NCT01737905) | Amphastar Pharmaceuticals, Inc. | 2012-10-01 |
| MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects (NCT01691859) | GlaxoSmithKline | 2012-09-28 |
| Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma (NCT01687283) | GlaxoSmithKline | 2012-09-27 |
| An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma. (NCT01686633) | GlaxoSmithKline | 2012-09-20 |
| Airway Inflammation and Remodeling in Asthma and COPD. (NCT02069054) | Medical University of Warsaw | 2012-09-01 |
| Implementation of ACT Through Facebook for Teenagers With Asthma (NCT01675921) | Massachusetts General Hospital | 2012-09-01 |
| Healthy Eating Better Breathing: A Feeding Study in Patients With Asthma (NCT02904655) | Johns Hopkins University | 2012-09-01 |
| T Cell Effector and Regulatory Mechanisms in Asthma (NCT01612936) | Andrew D. Luster, M.D.,Ph.D. | 2012-09-01 |
| Sample Collection in Smoking Asthma (NCT01676467) | Respivert Ltd | 2012-09-01 |
| Effectiveness of Influenza Vaccine Reminder Systems (NCT01852656) | Kaiser Permanente | 2012-09-01 |
| Aura Adolescent PK Study GSK2829332 (NCT01653483) | GlaxoSmithKline | 2012-09-01 |
| Assessment of Activity Limitation in Asthma Patients (NCT01962142) | Centre Hospitalier Universitaire Saint Pierre | 2012-09-01 |
| A Pilot Study of Personalized Medicine for Pediatric Asthma (NCT01681732) | Milton S. Hershey Medical Center | 2012-09-01 |
| Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication (NCT01696071) | Boehringer Ingelheim | 2012-09-01 |
| Safety and Efficacy of WIN-901X in Asthma (NCT01820481) | Whanin Pharmaceutical Company | 2012-09-01 |
| A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012) (NCT01656395) | Merck Sharp & Dohme LLC | 2012-08-23 |
| A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI) (NCT01669070) | GlaxoSmithKline | 2012-08-15 |
| Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011) (NCT01624974) | Merck Sharp & Dohme LLC | 2012-08-09 |
| Prehospital Emergency Care of Obstructive Respiratory Emergencies With the Use of Teleconsultation (NCT01644045) | RWTH Aachen University | 2012-08-01 |
| Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled Asthma (NCT01881412) | Rhode Island Hospital | 2012-08-01 |
| A Study of Inhaler Use in the Community (NCT02552472) | Beaumont Hospital | 2012-08-01 |
| Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (NCT01668121) | Orion Corporation, Orion Pharma | 2012-08-01 |
| Understanding and Appraising the New Medicine Service in England (NCT01635361) | University of Nottingham | 2012-08-01 |
| Evaluation of Halotherapy as Asthma Treatment in Children (NCT02772341) | Rambam Health Care Campus | 2012-08-01 |
| Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent Asthma (NCT01609478) | Novartis Pharmaceuticals | 2012-08-01 |
| Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer (NCT01795742) | Marquette University | 2012-08-01 |
| Study of the Effect of Innate on the Inflammatory Response to Endotoxin (NCT01143480) | National Institute of Environmental Health Sciences (NIEHS) | 2012-07-30 |
| A Study in Patients With Asthma (NCT01570478) | Chiesi Farmaceutici S.p.A. | 2012-07-01 |
| Effect of Aerobic Training in Moderate or Severe Asthmatic Patients (NCT02033122) | Instituto de Investigação em Imunologia | 2012-07-01 |
| The Electronic Asthma Action Plan System for Implementation in Primary Care (NCT01070095) | Unity Health Toronto | 2012-07-01 |
| A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma (NCT01591044) | Rigel Pharmaceuticals | 2012-07-01 |
| Asthma and Indoor-air: Reducing Exposures (NCT01869543) | University of California, Davis | 2012-07-01 |
| Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma (NCT01634152) | Boehringer Ingelheim | 2012-07-01 |
| Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients With Asthma (CPAP) (NCT01629823) | American Lung Association Asthma Clinical Research Centers | 2012-07-01 |
| A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects (NCT01653756) | SecuraBio | 2012-07-01 |
| Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients (NCT01651598) | Boehringer Ingelheim | 2012-07-01 |
| ENLaCE Pilot Study (NCT01641211) | University of North Carolina, Chapel Hill | 2012-07-01 |
| Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma (NCT01634113) | Boehringer Ingelheim | 2012-07-01 |
| Vitamin D, Steroids, and Asthma in African American Youth (NCT01647399) | Robert J. Freishtat | 2012-07-01 |
| Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma (NCT01634139) | Boehringer Ingelheim | 2012-07-01 |
| Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma (NCT01555151) | Novartis Pharmaceuticals | 2012-07-01 |
| Effects of Montelukast on Airway Regulatory T Cells in Asthma (NCT01951898) | Kurume University | 2012-06-01 |
| Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis (NCT01577628) | Cosmetique Active International | 2012-06-01 |
| A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans (NCT01514760) | Arkansas Children's Hospital Research Institute | 2012-06-01 |
| Mechanism and Dynamics of Bronchial Hyper-reactivity to Methacholine in Distal Airway on Obese Patients With Asthma (NCT03102749) | University Hospital, Montpellier | 2012-06-01 |
| An Open Label Placebo Study to Assess the Inhalation Profile in Asthmatic Patients Using the Nexthaler® Dry Powder Inhaler (DPI) Device (NCT01651650) | Chiesi Farmaceutici S.p.A. | 2012-06-01 |
| INCAS - Integrated Care of Asthma in Switzerland (NCT02425293) | Cantonal Hosptal, Baselland | 2012-06-01 |
| Asthma Comparative Effectiveness Study (NCT01623544) | AstraZeneca | 2012-06-01 |
| Asthma Data Innovation Demonstration Project (NCT02162576) | David Van Sickle | 2012-06-01 |
| A Study to Explore the Utility of Fractional Exhaled Nitric Oxide (FeNO) Compared With Methacholine Challenge (MCC) Testing in the Assessment of Patients With Suspected But Undiagnosed Asthma (NCT01648920) | Aerocrine AB | 2012-06-01 |
| Effects of Multidisciplinary Interventions in Elderly Asthma Patients With Risk of Acute Exacerbation (NCT01843439) | Sang-Heon Cho | 2012-06-01 |
| Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma (NCT01511302) | Revalesio Corporation | 2012-06-01 |
| Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma (NCT01584804) | The First Affiliated Hospital of Guangzhou Medical University | 2012-06-01 |
| Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte (NCT01627158) | Orion Corporation, Orion Pharma | 2012-06-01 |
| Efficacy and Safety of Mometasone Furoate for Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids (ICS) (Study P06115) (NCT01026870) | Organon and Co | 2012-06-01 |
| Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate Asthma (NCT01641081) | AstraZeneca | 2012-06-01 |
| A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma (NCT01551147) | Ono Pharma USA Inc | 2012-06-01 |
| Glasgow Asthma and Allergy Study (NCT01618318) | National Services for Health Improvement Ltd | 2012-06-01 |
| mRNA Expression as a Biomarker of Omalizumab Response (NCT01584687) | Instituto de Investigação em Imunologia | 2012-06-01 |
| My MediHealth: A Paradigm for Children-centered Medication Management (NCT01730235) | Vanderbilt University | 2012-05-01 |
| Prediction of Future Risk in Patients With Controlled Asthma (NCT01565031) | Luis Perez de Llano | 2012-05-01 |
| The Development of a Clinical Test to Assess the Inflammatory Phenotype of Asthma (NCT01611012) | Prof. Jan-Willem Lammers MD PhD | 2012-05-01 |
| The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples (NCT01631162) | Carmel Medical Center | 2012-05-01 |
| A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma (NCT01641692) | GlaxoSmithKline | 2012-05-01 |
| Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler (NCT01593826) | Orion Corporation, Orion Pharma | 2012-05-01 |
| Small Airways Disease in Asymptomatic and Symptomatic Subjects With Airway Hyperresponsiveness (AHR) (NCT01549483) | University Medical Center Groningen | 2012-05-01 |
| Effectiveness of Pharmacist Interventions in Difficult Asthma (NCT02363192) | The Leeds Teaching Hospitals NHS Trust | 2012-05-01 |
| Imaging Study of the Lungs During an Allergic Asthma Attack (NCT01547286) | Massachusetts General Hospital | 2012-05-01 |
| Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts (NCT01608243) | Stallergenes Greer | 2012-05-01 |